KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Shares Outstanding (Weighted Average): 2009-2024

Historic Shares Outstanding (Weighted Average) for Nektar Therapeutics (NKTR) over the last 16 years, with Dec 2024 value amounting to $12.3 million.

  • Nektar Therapeutics' Shares Outstanding (Weighted Average) rose 54.97% to $19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.0 million, marking a year-over-year increase of 54.97%. This contributed to the annual value of $12.3 million for FY2024, which is 3.31% down from last year.
  • Nektar Therapeutics' Shares Outstanding (Weighted Average) amounted to $12.3 million in FY2024, which was down 3.31% from $12.7 million recorded in FY2023.
  • Nektar Therapeutics' Shares Outstanding (Weighted Average)'s 5-year high stood at $12.7 million during FY2023, with a 5-year trough of $12.0 million in FY2020.
  • Over the past 3 years, Nektar Therapeutics' median Shares Outstanding (Weighted Average) value was $12.5 million (recorded in 2022), while the average stood at $12.5 million.
  • Per our database at Business Quant, Nektar Therapeutics' Shares Outstanding (Weighted Average) climbed by 2.88% in 2021 and then declined by 3.31% in 2024.
  • Nektar Therapeutics' Shares Outstanding (Weighted Average) (Yearly) stood at $12.0 million in 2020, then grew by 2.88% to $12.3 million in 2021, then grew by 1.84% to $12.5 million in 2022, then rose by 1.50% to $12.7 million in 2023, then fell by 3.31% to $12.3 million in 2024.